Regular transfusion lowers plasma free hemoglobin in children with sickle-cell disease at risk for stroke

Stroke

Volumn 37, Issue 6, 2006, Pages 1424-1426

  Lezcano, Nelson E ^a   Odo, Nadine ^a   Kutlar, Abdullah ^a   Brambilla, Donald ^b   Adams, Robert J ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b NEW ENGLAND RESEARCH INSTITUTES   (United States)

Author keywords

Children; Hemolysis; Stroke

Indexed keywords

BILIRUBIN; HEMOGLOBIN; LACTATE DEHYDROGENASE;

ARTICLE; BILIRUBIN BLOOD LEVEL; CHILD; CONTROLLED STUDY; ERYTHROCYTE TRANSFUSION; FEMALE; HEMOGLOBIN BLOOD LEVEL; HEMOLYSIS; HIGH RISK PATIENT; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK REDUCTION; SICKLE CELL ANEMIA; STROKE; TREATMENT OUTCOME; BLOOD; BLOOD TRANSFUSION; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; METABOLISM; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

ANEMIA, SICKLE CELL; BILIRUBIN; BLOOD TRANSFUSION; CEREBROVASCULAR ACCIDENT; CHILD; HEMOGLOBINS; HUMANS; L-LACTATE DEHYDROGENASE; RISK FACTORS;

EID: 33745141905     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000221173.97108.01     Document Type: Article

References (13)

1. Ohene-Frempong K, Weiner SJ, Sleeper LA, Miller ST, Embury S, Moohr JW, Wethers DL, Pegelow CH, Gill FM. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood. 1998;91:288-294.
2. Prengler M, Pavlakis SG, Prohovnik I, Adams R. Sickle cell disease: the neurological complications. Ann Neurol. 2002;51:543-552.
3. Adams R, McKie V, Nichols F, Carl E, Zhang DL, McKie K, Figueroa R, Litaker M, Thompson W, Hess D. The use of transcranial ultrasonography to predict stroke in sickle-cell disease. N Engl J Med. 1992;326:605-610.
4. Adams RJ, McKie VC, Hsu L, Files B, Vichinsky E, Pegelow C, Abboud M, Gallagher D, Kutlar A, Nichols FT, Bonds DR, Brambilla D. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonograpy. N Engl J Med. 1998;339:5-11.
5. Naumann HN, Diggs LW, Barreras L, Williams BJ. Plasma hemoglobin and hemoglobin fractions in sickle cell crisis. Am Journal of Clinical Pathology. 1971;56:137-147.
6. Jison ML, Gladwin MT. Hemolytic anemia-associated pulmonary hypertension of sickle cell disease and the nitric oxide/arginine pathway. Am Journal of Respiratory and Crit Care Med. 2003;168:3-4.
7. Reiter C, Wang X, Tanus-Santos J, Hogg N, Cannon R III, Schechter A, Gladwin M. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med. 2002;8:1383-1389.
8. Rother RP, Bell L, Hillmen P, Gladwin MT. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. J Am Med Assoc. 2005;293:1653-1662.
9. Brian JE Jr, Faraci FM, Heistad DD. Recent insights into the regulation of cerebral circulation. Clin Exp Pharmacol Physiol. 1996;23:449-457.
10. Neely CL, Wajima T, Kraus AP, Diggs LW, Barreras L. Lactic acid dehydrogenase activity and plasma hemoglobin elevations in sickle cell disease. Am J Clin Pathol. 1969;52:167-169.
11. Kutlar A, Harbin J, Jackson B, Holley L, Gallagher D, Clair B, Brambilla D, Adams RJ, McKie V, Hsu L, Files B, Vichinsky E, Pegelow C, Abboud M, Woods G, Olivieri N, Driscoll C, Miller S, Wang W, Piomelli S, Scher C, Berman B. Laboratory parameters in patients randomized in the STOP study and their modification by transfusion. Blood. 2000;96:18b.
12. Jeney V, Balla J, Yachie A, Varga Z, Vercellotti GM, Eaton J, Balla G. Pro-oxidant and cytotoxic effects of circulating heme. Blood. 2002;100:879-887.
13. Hebbel RP, Osarogiagbon R, Kaul D. The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy. Microcirculation. 2004;11:129-151.